Nerve News and Research

RSS

Effects of Huntington's disease mutation more complex than originally thought

Competing theories about why brain cells die in Huntington's disease may not be competitors after all, according to a report published July 21, 2004, in the online edition of the Annals of Neurology.

22 Jul 2004

Women twice as likely as men to develop some musculoskeletal disorders

Musculoskeletal pain is an extremely common problem. In this age of fitness promotion, many people develop musculoskeletal disorders related to overuse of weak or improperly stretched muscles, tendons or ligaments. Strenuous daily vocational activities, such as lifting, bending, or prolonged typing, can cause musculoskeletal pain through constant stress on the musculoskeletal system.

22 Jul 2004

We know they need caffeine, but how it works on the newborn is the subject of a new study

Every morning, millions of adults consume voluminous cups of coffee, seeking the jolting effect of caffeine. As these adults consume their coffee, they do so unaware that some of the youngest Americans are also getting a treatment of caffeine - not to stay awake, but to assist in treating a major sleep disorder found in some neonates.

21 Jul 2004

Botox approved as treatment for severe underarm sweating

The FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as “primary axillary hyperhidrosis” that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes.

20 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

New drugs that can prevent scarring in the eye after glaucoma surgery

Highly innovative new drugs that can prevent scarring in the eye after glaucoma surgery have been discovered by a London-based team of scientists, who report today in the journal Nature Biotechnology.

19 Jul 2004

Botulism case associated with consumption of a salt-cured fish product

A 41 year old New Jersey resident was hospitalized on June 3, 2004 with a confirmed case of botulism.

15 Jul 2004

New research into what causes endometriosis

Researchers know what causes endometriosis, but how the cysts that are characteristic of the disease maintain themselves and produce severe pain in some women has remained a mystery.

15 Jul 2004

Using a combination of therapies and cell grafts could help treat patients with chronic spinal cord injuries

Using a combination of therapies and cell grafts, a team of University of California, San Diego (UCSD) School of Medicine researchers has promoted significant regeneration of nerve cells in rats with spinal cord injury.

15 Jul 2004

Novel tool that can be used to visualize single neurons in living brain tissue

Carnegie Mellon University neuroscientist Alison Barth has developed the first tool to identify and study individual neurons activated in a living animal.

15 Jul 2004

Women with a condition called vulvodynia process pain differently

The researchers tested 17 women with vulvodynia and 23 similar women without pain at 23 sites throughout the vulva and at the deltoid muscle, the shin and the thumbnail to assess pain tolerance. They found the women with vulvodynia had lower tolerance at all sites than the women without vulvodynia.

13 Jul 2004

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

Glaucoma is a condition in which the pressure inside the eyes rises. If untreated, glaucoma may damage the optic nerve and other parts of the eye, and my lead to blindness. According to information in the article, latanoprost is a derivative of the chemical prostaglandin F2-alpha. Prostaglandin derivatives have been shown to help lower intraocular pressure (IOP).

13 Jul 2004

New hereditary spastic paraplegia research

In work reported this week, researchers have taken our understanding of HSP to a new level with the development of an animal model for the disease.

13 Jul 2004

Having a good time can strengthen different centres in the brain and help it grow healthy brain cells

Dr Ian Reid, professor of mental health at the University of Aberdeen, told delegates that for many years psychiatrists believed that poor mental health was just caused by imbalances in various brain chemicals.

10 Jul 2004

Mitochondria in spinal cords is Lou Gehrig’s disease target according researchers

The selective killing of spinal cord neurons in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, occurs when tiny cellular components called mitochondria actively recruit a mutant disease-causing protein into specific neuron cells, according to new research by University of California, San Diego (UCSD) School of Medicine investigators.

9 Jul 2004

Identification of a naturally occurring genetic difference that controls the production of serotonin in the brain

Researchers at Duke University Medical Center have provided the first direct evidence in mice for the role of an enzyme that specifically controls the production of serotonin in the brain.

8 Jul 2004

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Research into the action of a key cancer gene has serendipitously uncovered its vital role in nerve growth, Cancer Research UK scientists reveal in a paper published on Wednesday.

8 Jul 2004

Possibility of generating nerve cells from an individual’s own skin cells

Results of an experimental study in this week’s issue of THE LANCET highlight how adult skin cells can be made into precursor nerve cells, with potential implications for the future treatment of neurodegenerative disorders such as Parkinson’s disease.

8 Jul 2004

Key proteins that regulate neurofibromatosis could be targets for new drugs

More than 100,000 Americans suffer from the painful and debilitating genetic disorder known as neurofibromatosis, or NF, which causes tumors to grow in various types of nerve tissue throughout the body.

7 Jul 2004

Research to unravel exactly what is going on chemically, when Alzheimer's sets in

Science understands Alzheimer's disease as the progressive decline of a particular region of the brain. But the underlying mechanisms leading to this decline are still very much a mystery.

7 Jul 2004

Nerve News and Research

Effects of Huntington's disease mutation more complex than originally thought

Women twice as likely as men to develop some musculoskeletal disorders

We know they need caffeine, but how it works on the newborn is the subject of a new study

Botox approved as treatment for severe underarm sweating

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

New drugs that can prevent scarring in the eye after glaucoma surgery

Botulism case associated with consumption of a salt-cured fish product

New research into what causes endometriosis

Using a combination of therapies and cell grafts could help treat patients with chronic spinal cord injuries

Novel tool that can be used to visualize single neurons in living brain tissue

Women with a condition called vulvodynia process pain differently

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

New hereditary spastic paraplegia research

Having a good time can strengthen different centres in the brain and help it grow healthy brain cells

Mitochondria in spinal cords is Lou Gehrig’s disease target according researchers

Identification of a naturally occurring genetic difference that controls the production of serotonin in the brain

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Possibility of generating nerve cells from an individual’s own skin cells

Key proteins that regulate neurofibromatosis could be targets for new drugs

Research to unravel exactly what is going on chemically, when Alzheimer's sets in

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News